Beatriz Castello Branco

Beatriz Castello Branco

Auto-generated profile, based on publicly available information

Beatriz Castello Branco

Advanced Arrhythmia Treatment Center (CTA) , Av. Barbacena, 472, Belo Horizonte, MG 30190-130

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
AFAnna Terra França
Anna Terra França
LMLarissa Natany Almeida Martins
Larissa Natany Almeida Martins
DODerick Matheus de Oliveira
Derick Matheus de Oliveira
FCFábio Morato de Castilho
Fábio Morato de Castilho
BBBeatriz Castello Branco
Beatriz Castello Branco
ACAndré Assis Lopes Do Carmo
André Assis Lopes Do Carmo

1 April 2023 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BBBeatriz Castello Branco
Beatriz Castello Branco
BWBruno Wilnes
Bruno Wilnes
PCPedro Alves Soares Vaz de Castro
Pedro Alves Soares Vaz de Castro
CLCaio Ribeiro Vieira Leal
Caio Ribeiro Vieira Leal
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
The posterior urethral valve (PUV) is one of the main causes of congenital obstruction of the lower urinary tract in pediatrics. Its occurrence, although rare, can cause chronic kidney disease (CKD), with frequent progression to end stage kidney disease. Therefore, the development of new diagnostic strategies, such as biomarkers, is crucial to better assess the prognosis of patients with PUV. We aimed to review the literature on traditional and new biomarkers in PUV. For that, searches were performed in PubMed/MEDLINE, Scopus and SciELO databases. To systematize the search, terms such as “Posterior Urethral Valve”, “Prognosis”, “Biomarkers” and variations described in the Medical Subject Headings (MeSH) database were used. The literature showed new biomarkers of disease prognosis, with emphasis on inflammatory cytokines, proteomics and genomics techniques, as well as classic biomarkers, focusing on serum creatinine and urine osmolality. As for biomarkers recently described in the literature, the 12PUV, a set of 12 fetal urinary peptides that accurately predicted postnatal kidney function in fetuses with PUV, stands out. Similarly, oxidative stress markers, inflammatory cytokines and components of the renin-angiotensin system (RAS), when increased, were indicative of severe kidney outcomes. Genetic alterations also correlated to worse prognosis among patients with PUV, with emphasis on RAS polymorphisms and, specifically, those affecting the angiotensin-converting enzyme (ACE) and the angiotensin II receptors types 1 and 2 (AGTR1 and AGTR2) genes. Considering the severity of the PUV condition, the identification of sensitive and cost-effective biomarkers, beyond improving diagnosis, may favor the investigation of new therapeutic strategies.

6 April 2025 in Heart Rhythm
Verified
Journal Article
Closed access
BWBruno Wilnes
Bruno Wilnes
BCBeatriz Castello-Branco
Beatriz Castello-Branco
EPEduardo Maia Martins Pereira
Eduardo Maia Martins Pereira
LLLuiza Marinho Lopes
Luiza Marinho Lopes
VSVivian Barroso Santos
Vivian Barroso Santos
ACAndre Assis Lopes Do Carmo
Andre Assis Lopes Do Carmo

22 January 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
RARenata Araujo Avendanha
Renata Araujo Avendanha
GCGuilherme Figueiredo Coelho Campos
Guilherme Figueiredo Coelho Campos
BBBeatriz Castello Branco
Beatriz Castello Branco
NINicolle Coimbra Ishii
Nicolle Coimbra Ishii
LGLuiz Henrique Nacife Gomes
Luiz Henrique Nacife Gomes
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva